BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Novartis Pharmaceuticals Canada Inc. 

385 Bouchard Boulevard

Dorval  Quebec  H9S 1A9  Canada
Phone: 514-631-6775 Fax:


SEARCH JOBS



Segment
Pharmaceuticals





 Company News
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Bexsero®: First Vaccine To Prevent Meningococcal Serogroup B (MenB) Now Available In Canada 2/26/2014 11:44:25 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Receives Health Canada Approval For Ultibro ™ Breezhaler ®, A Once-Daily Dual Bronchodilator For COPD 1/14/2014 10:33:33 AM    More...
Health Canada Approves Novartis Pharmaceuticals Canada Inc. (NVS)'s Bexsero*, The First Vaccine Available To Prevent Meningococcal Serogroup B (MenB)(1,2) 12/9/2013 7:01:39 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Release: New Study Confirms Seasonal Flu Vaccine Designed for Seniors Improved Protection Against Influenza? 11/5/2013 8:51:07 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Continues to Build Its COPD Pipeline and Presents New Data on Investigational Once-Daily QVA149 at ERS 9/9/2013 8:05:09 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Now Available in Ontario, (Pr)SEEBRI* BREEZHALER*, a Long-Term Once-Daily Maintenance Treatment for Chronic Obstructive Pulmonary Disease (COPD) 9/3/2013 10:09:22 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Resumes Seasonal Influenza Vaccine Distribution as Health Canada Lifts Suspension 11/1/2012 10:00:07 AM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Canadian Agency for Drugs and Technologies in Health (CADTH) Recommends Provincial and Publicly Funded Drug Plans Reimburse (Pr)Lucentis* to Treat Vision Loss Resulting From Diabetic Macular Edema (DME) 3/29/2012 9:43:37 AM    More...
Health Canada Removes Novartis Pharmaceuticals Canada Inc. (NVS)'s Cox-2 Drug Prexige from the Market over Liver Problems 10/4/2007 1:21:42 PM    More...
Novartis Pharmaceuticals Canada Inc. (NVS) Pulls Prexige From Canada on Safety Issues 10/4/2007 10:04:38 AM    More...
12

//-->